Correction to: Novel and potent inhibitors targeting DHODH are broad-spectrum antivirals against RNA viruses including newly-emerged coronavirus SARS-CoV-2 (Protein & Cell, (2020), 11, 10, (723-739), 10.1007/s13238-020-00768-w)

Rui Xiong; Leike Zhang; Shiliang Li; Yuan Sun; Minyi Ding; Yong Wang; Yongliang Zhao; Yan Wu; Weijuan Shang; Xiaming Jiang; Jiwei Shan; Zihao Shen; Yi Tong; Liuxin Xu; Yu Chen; Yingle Liu; Gang Zou; Dimitri Lavillette; Zhenjiang Zhao; Rui Wang; Lili Zhu; Gengfu Xiao; Ke Lan; Honglin Li; Ke Xu

ArticleOPEN ACCESS

Correction to: Novel and potent inhibitors targeting DHODH are broad-spectrum antivirals against RNA viruses including newly-emerged coronavirus SARS-CoV-2 (Protein & Cell, (2020), 11, 10, (723-739), 10.1007/s13238-020-00768-w)

Protein and Cell

DOI: 10.1007/s13238-020-00801-y

1Citations

10Readers

Abstract

In the original publication the author’s name ‘Dimitri Lavillete’ is published incorrectly. The correct author name should be spelt as ‘Dimitri Lavillette’ is provided in this correction.

Cite

CITATION STYLE

APA

Xiong, R., Zhang, L., Li, S., Sun, Y., Ding, M., Wang, Y., … Xu, K. (2022, October 1). Correction to: Novel and potent inhibitors targeting DHODH are broad-spectrum antivirals against RNA viruses including newly-emerged coronavirus SARS-CoV-2 (Protein & Cell, (2020), 11, 10, (723-739), 10.1007/s13238-020-00768-w). Protein and Cell. Higher Education Press Limited Company. https://doi.org/10.1007/s13238-020-00801-y

Correction to: Novel and potent inhibitors targeting DHODH are broad-spectrum antivirals against RNA viruses including newly-emerged coronavirus SARS-CoV-2 (Protein & Cell, (2020), 11, 10, (723-739), 10.1007/s13238-020-00768-w)

Abstract

Cite

Register to see more suggestions